| 摘要 |
<p>An ophthalmic composition containing a geranylgeranylacetone selected from (a), (b) or (c) mentioned below protects various retina cells from degeneration, disorder or annihilation, and significantly promotes the survival of said cells. Therefore, said composition exerts a dramatic effect in the prevention, amelioration or treatment of various retina disorders. Moreover, the composition is less likely to become cloudy when being stored. (a) A mixture of 5E,9E,13E-geranylgeranylacetone and 5Z,9E,13E-geranylgeranylacetone, the mixture containing 80 weight% or more of the 5E,9E,13E-geranylgeranylacetone; (b) only 5E,9E,13E-geranylgeranylacetone; (c) only 5Z,9E,13E-geranylgeranylacetone.</p> |
